IP Library › Granted Patent US 12,296,165
Granted Patent B2
US 12,296,165 · App. 18/542,883 · Granted May 13, 2025

Ejaculation control

Inventors: Tal Gollan (Ramat-Gan, IL); Gideon Meiri (Kibbutz Shomrat, IL); Oded Shlomo Kraft-Oz (Haifa, IL)
Assignee: Virility Medical Ltd.
A61N1/36007A61F5/41A61N1/0452A61N1/0456A61N1/0476A61N1/36031A61F2005/418
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,296,165
App. No.
18/542,883
Granted
May 13, 2025
Kind
B2
Abstract

A device for electrifying perineal tissue, including: a housing shaped and sized to be attached to a perineum surface of a subject between a posterior aspect of the scrotum and the anus of the subject; at least two electrodes in the housing configured to deliver an electric field to a perineal tissue, wherein the electrodes are positioned entirely between the scrotum and the anus; a pulse generator in the housing electrically connected to the at least two electrodes, wherein the pulse generator generates an electric field with parameter values selected to affect at least one selected target within the perineal tissue; a control circuitry in the housing electrically connected to the pulse generator; a readable and writable memory circuit in the housing electrically connected to the control circuitry, wherein the readable and writable memory stores indications of at least one electric field parameter and/or at least one treatment program.

Claims (39)

1. A device for electrifying perineal tissue, comprising:

a housing shaped and sized to be positioned on a perineum surface of a subject between a posterior aspect of a scrotum and an anus of said subject, wherein said housing comprises an attachment element configured to attach a surface of said housing to said perineum surface of said subject and to keep said device attached to said perineum surface between said posterior aspect of the scrotum and said anus during sexual intercourse;

at least two electrifying electrodes in said housing, positioned entirely on a skin surface between said posterior aspect of the scrotum and the anus, said at least two electrifying electrodes configured to deliver an electric field to a bulbospongiosus muscle of said subject and/or innervating nerves thereto;

a control circuitry in said housing;

a pulse generator in said housing electrically connected to said at least two electrifying electrodes and said control circuitry,

wherein said control circuitry is configured to signal said pulse generator to generate the electric field in accordance with at least one electric field parameter comprising a pre-determined electric field intensity level and at least one treatment parameter comprising a ramp time of at least 5 seconds, whereby said generated electric field increases to reach said pre-determined intensity level during said ramp time; and

said at least one electric field parameter, including said intensity level, and said at least one treatment parameter, including said ramp time, are selected to inhibit rhythmic contractions of said bulbospongiosus muscle and affect a physiological ejaculatory process in said subject during said delivery of said electric field when said device is attached to said perineum surface during said sexual intercourse.

2. A device according to claim 1 , wherein a distance between the at least two electrifying electrodes is between 10 to 14 mm.

3. A device according to claim 1 , wherein said housing is thin and flexible enough to bend and conform to the anatomical curvature of the perineum.

4. A device according to claim 1 , wherein said pulse generator is configured to generate and deliver an electric field configured to prolong an Ejaculatory Latency Time (ELT) in at least two-fold compared to the ELT duration without electric field delivery.

5. A device according to claim 1 , comprising at least one sensor in said flexible housing for measuring at least one physiological parameter.

6. A device according to claim 1 , wherein said device is connected to at least one sensor configured to measure at least one physiological parameter.

7. A device according to claim 5 , wherein said at least one physiological parameter comprises heart rate.

8. A device according to claim 1 , wherein said device comprises at least one electrode or sensor for measuring impedance of the generated electric field, and wherein said device is further configured to perform at least one of:

generating a human detectable indication when values of said measured impedance are higher than 3000 ohm; and

stop generating said electric field if said measured impedance values are higher than 5000 ohm.

9. A device according to claim 1 , wherein said device comprises at least one electrode or sensor for measuring values of at least one electrical parameter of the electric field, and wherein said control circuitry calculates impedance based on said measured values of said at least one electrical parameter of the electric field.

10. A device according to claim 1 , wherein said housing comprises at least one longitudinal bending line for bending the device to conform to the anatomical curvature of the perineum between the creases of the thighs.

11. A device according claim 1 , wherein said housing comprises at least one transverse bending line for bending the device to conform to the anatomical curvature of the perineum between the posterior aspect of the scrotum and the anus.

12. A device according to claim 1 , wherein said housing comprises a proximal region with an inward curve shaped and sized to generally follow a posterior aspect of the scrotum and a distal region shaped and sized to be positioned near the anus.

13. A device according to claim 1 , wherein a surface area of said at least two electrifying electrodes is in a range between 90 mm 2 and 850 mm 2 .

14. A device according to claim 1 , comprising at least one sensor or electrode electrically connected to said control circuitry for measuring values of at least one physiological parameter of said subject, and wherein said control circuitry is further configured to signal said pulse generator to generate said electric field if said measured values are higher than a predetermined value and/or if said measured values are in a desired range.

15. A device according claim 1 , wherein said at least one selected target comprises the bulbospongiosus muscle, nerves innervating the bulbospongiosus muscle, ischiocavernosus muscle, nerves innervating the ischiocavernosus muscle, or any combination thereof.

16. A method for electrifying nerves and/or muscles of a perineum of a subject, comprising:

positioning a device configured to deliver an electric field to selected targets in the perineum to the perineum skin between a posterior aspect of a scrotum and an anus of said subject, said device comprising an attachment element configured to attach a surface of said device to a perineal surface of said subject and to keep said device attached to said perineum between said posterior aspect of the scrotum and said anus during sexual intercourse;

generating said electric field by a pulse generator of said device, according to at least one electric field parameter comprising a pre-determined intensity level and at least one treatment program comprising a ramp time of at least 5 seconds, whereby said generated electric field increases to reach said pre-determined intensity level during said ramp time; and

delivering said electric field to said nerves and/or muscles of the perineum by at least two electrifying electrodes of the device,

wherein said electrifying electrodes are disposed entirely on a skin surface between said posterior aspect of the scrotum and said anus; and

said at least one electric field parameter, including said intensity level, and said at least one treatment parameter, including said ramp time, are selected to inhibit rhythmic contractions of said bulbospongiosus muscle and delay an ejaculation in said subject during said delivery of said electric field when said device is attached to said perineum surface during said sexual intercourse.

17. The method of claim 16 , further comprising measuring, by at least one sensor in said housing, at least one physiological parameter.

18. The method of claim 16 , further comprising measuring, by at least one electrode or sensor of said device, impedance of the generated electric field and one or more, by said device, of:

generating a human detectable indication when values of said measured impedance are higher than 3000 ohm; and

stop generating said electric field if said measured impedance values are higher than 5000 ohm.

19. The method of claim 16 , further comprising:

measuring, by at least one electrode or sensor said device, values of at least one electrical parameter of the electric field; and

calculating, by said control circuitry, impedance based on said measured values of said at least one electrical parameter of the electric field.

20. The method of claim 16 , further comprising:

measuring, by at least one sensor or electrode electrically connected to said control circuitry, values of at least one physiological parameter of said subject; and

generating, by said pulse generator, said electric field if said measured values are higher than a predetermined value and/or if said measured values are in a desired range.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2024
From: GOLLAN, TAL; MEIRI, GIDEON; KRAFT-OZ, ODED SHLOMO
To: VIRILITY MEDICAL LTD.
Reel/Frame 066106/0698 →
Continuity (3)
Continuation 16957752
Provisional Application 62610535 · Dec 27, 2017
Related Publication 20240115858A1 · Apr 11, 2024
References Cited (107)
US 5562717A · Tippey et al. · 1996 [cited by applicant]
US 7894913B2 · Boggs et al. · 2011 [cited by applicant]
US 8876696B2 · Mikhailenok et al. · 2014 [cited by applicant]
US 9149634B2 · Lee · 2015 [cited by examiner]
US 9370652B2 · Lin et al. · 2016 [cited by applicant]
US 9764010B2 · Nilsson Neijber · 2017 [cited by applicant]
US 10773072B2 · Gollan · 2020 [cited by applicant]
US 12069658B2 · Takano · 2024 [cited by applicant]
US 20060020297A1 · Gerber et al. · 2006 [cited by applicant]
US 20070055337A1 · Tanrisever · 2007 [cited by applicant]
US 20080161874A1 · Bennett et al. · 2008 [cited by applicant]
US 20090182393A1 · Bachinski · 2009 [cited by applicant]
US 20100016759A1 · Lavoisier · 2010 [cited by applicant]
US 20130006322A1 · Tai · 2013 [cited by applicant]
US 20130116742A1 · Lavoisier · 2013 [cited by applicant]
US 20140074179A1 · Heldman et al. · 2014 [cited by applicant]
US 20140155954A1 · Lee · 2014 [cited by applicant]
US 20140324120A1 · Bogie et al. · 2014 [cited by applicant]
US 20150290450A1 · Kolb et al. · 2015 [cited by applicant]
US 20150335288A1 · Toth · 2015 [cited by examiner]
US 20160015553A1 · Caldarone · 2016 [cited by applicant]
US 20160015962A1 · Shokoueinejad Maragheh et al. · 2016 [cited by applicant]
US 20160263376A1 · Yoo et al. · 2016 [cited by applicant]
US 20160303370A1 · Sharma · 2016 [cited by applicant]
US 20170014632A1 · Kimura · 2017 [cited by applicant]
US 20180043157A1 · Sharma · 2018 [cited by applicant]
US 20180168919A1 · Fung · 2018 [cited by applicant]
US 20180345003A1 · Gollan · 2018 [cited by applicant]
US 20210016078A1 · Gollan · 2021 [cited by applicant]
US 20210236805A1 · Gollan · 2021 [cited by applicant]
CA 2913074 · 2014 [cited by applicant]
CN 103550860 · 2014 [cited by applicant]
EP 2237831 · 2010 [cited by applicant]
EP 3131622 · 2017 [cited by applicant]
JP 08501946 · 1996 [cited by applicant]
JP 2000167067 · 2000 [cited by applicant]
JP 2011519646 · 2011 [cited by applicant]
JP 2011213617 · 2011 [cited by applicant]
JP 2016523125 · 2016 [cited by applicant]
KR 102011030443 · 2011 [cited by applicant]
KR 101416612 · 2014 [cited by applicant]
RU 2207162 · 2003 [cited by applicant]
RU 2248228 · 2005 [cited by applicant]
RU 2525619 · 2014 [cited by applicant]
WO WO2009089014A1 · 2009 [cited by applicant]
WO WO2011155089 · 2011 [cited by applicant]
WO WO2012116407 · 2012 [cited by applicant]
WO WO2016069090 · 2016 [cited by applicant]
WO WO2017075359 · 2017 [cited by applicant]
WO WO2017089887 · 2017 [cited by applicant]
WO WO2019130311 · 2019 [cited by applicant]
English Summary Dated Sep. 28, 2023 of Notification of Office Action Dated Sep. 13, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201880090395.5. (5 pages). [cited by applicant]
Grounds of Reason of Rejection Dated Aug. 28, 2023 From the Korean Intellectual Property Office Re. Application No. 10-2018-7017550 and Its Summary Into English. (11 Pages). [cited by applicant]
Machine Translation Dated Sep. 13, 2023 of Grounds of Reason of Rejection Dated Aug. 28, 2023 From the Korean Intellectual Property Office Re. Application No. 10-2018-7017550. (6 Pages). [cited by applicant]
Notification of Office Action and Search Report Dated Sep. 13, 2023 From the National Intellectual Property Administration of the People's Republic of China Re. Application No. 201880090395.5. (10 Pages). [cited by applicant]
Relatório de Exame Tecnico Dated Oct. 10, 2023 From the Serviço Público Federal, Ministério da Economia, Instituto Nacional da Propriedade Industrial do Brasil Re. Application No. BR 11 2018 010536 8 and Its Translation… [cited by applicant]
Grounds of Reason of Rejection Dated Nov. 16, 2023 From the Korean Intellectual Property Office Re. Application No. 10-2020-7021758 (8 Pages). [cited by applicant]
Machine Translation Dated Nov. 21, 2023 of Grounds of Reason of Rejection Dated Nov. 16, 2023 From the Korean Intellectual Property Office Re. Application No. 10-2020-7021758 (6 Pages). [cited by applicant]
Relatório de Exame Tecnico [Technical Examination Report] Dated May 23, 2023 From the Serviço Público Federal, Ministério da Economia, Instituto Nacional da Propriedade Industrial do Brasil Re. Application No. BR 11 201… [cited by applicant]
Notice of Reason(s) for Rejection Dated Jun. 6, 2023 From the Japan Patent Office Re. Application No. 2020-535215 and Its Translation Into English. (5 Pages). [cited by applicant]
Official Action Dated May 4, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/019,468. (34 pages). [cited by applicant]
Applicant-Initiated Interview Summary Dated Jan. 29, 2020 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/778,707. (3 pages). [cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Oct. 7, 2021 From the European Patent Office Re. Application No. 16868090.8. (3 Pages). [cited by applicant]
Examination Report Dated Jun. 28, 2021 From the Australian Government, IP Australia Re. Application No. 2016359227. (2 Pages). [cited by applicant]
Examination Report Under Sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003 Dated May 17, 2021 From the Government of India, Intellectual Property India, Patents, Designs, Trade Marks, Geographical In… [cited by applicant]
Final Official Action Dated Mar. 4, 2022 from US Patent and Trademark Office Rc. U.S. Appl. No. 17/233,602. (37 pages). [cited by applicant]
Final Official Action Dated Apr. 21, 2020 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/778,707. (24 pages). [cited by applicant]
International Preliminary Report on Patentability Dated Jun. 7, 2018 From the International Bureau of WIPO Re. Application No. PCT/IB2016/001731. (11 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated May 18, 2017 From the International Searching Authority Re. Application No. PCT/IB2016/001731. (15 Pages). [cited by applicant]
Interview Summary Dated Oct. 8, 2021 From the US Patent and Trademark Office Re. U.S. Appl. No. 17/233,602. (2 Pages). [cited by applicant]
Notice of Allowance Dated Jul. 15, 2020 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/778,707. (7 pages). [cited by applicant]
Notice of Allowance Dated Jul. 21, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 17/233,602. (9 pages). [cited by applicant]
Notice of Reason(s) for Rejection Dated Jan. 4, 2023 From the Japan Patent Office Re. Application No. 2020-535215 and Its Translation Into English. (20 Pages). [cited by applicant]
Notice of Reason(s) for Rejection Dated May 11, 2021 From the Japan Patent Office Re. Application No. 2018-525733 and Its Translation Into English.(6 Pages). [cited by applicant]
Notice of Reasons for Rejection Dated Oct. 27, 2020 From the Japan Patent Office Re. Application No. 2018-525733 and Its Translation Into English. (5 Pages). [cited by applicant]
Notification of Office Action Dated Jun. 18, 2021 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201680068609.X and Its Translation into English. (19 Pages). [cited by applicant]
Notification of Office Action and Search Report Dated Jan. 5, 2021 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201680068609.X and Its English Summary (18 Pages). [cited by applicant]
Office Action Dated Feb. 3, 2022 From the Israel Patent Office Re. Application No. 259474 and Its Translation Into English. (7 Pages). [cited by applicant]
Office Action Dated Apr. 12, 2021 From the Israel Patent Office Re. Application No. 259474 and Its Translation Into English. (6 Pages). [cited by applicant]
Official Action Dated Oct. 4, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/778,707. (24 pages). [cited by applicant]
Official Action Dated Oct. 4, 2022 From the US Patent and Trademark Office Re. U.S. Appl. No. 17/019,468. (51 Pages). [cited by applicant]
Official Action Dated Nov. 17, 2021 from US Patent and Trademark Office Re. U.S. Appl. No. 17/233,602. (32 pages). [cited by applicant]
Official Action Dated Jul. 23, 2021 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/233,602. (26 pages). [cited by applicant]
Patent Examination Report Dated Nov. 21, 2020 From the Australian Government, IP Australia Re. Application No. 2016359227. (5 Pages). [cited by applicant]
Requisition by the Examiner Dated Jan. 9, 2023 From the Innovation, Science and Economic Development Canada, Canadian Intellectual Property Office Rc. Application No. 3,004,513 and Claims. (14 pages). [cited by applicant]
Search Report and Opinion Dated Jul. 13, 2020 From the Servico Publico Federal, Ministerio da Economia, Instituto Nacional da Propriedade Industrial do Brasil Re. Application No. BR112018010536-8. (7 Pages). [cited by applicant]
Supplementary European Search Report and the European Search Opinion Dated Jul. 2, 2019 From the European Patent Office Re. Application No. 16868090.8. (6 Pages). [cited by applicant]
Examination Report Under Sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003 Dated Apr. 28, 2022 From the Government of India, Intellectual Property India, Patents, Designs, Trade Marks, Geographical I… [cited by applicant]
Request for Examination and Search Report Dated Mar. 1, 2022 From the Federal Government Institution, Federal Institute of Industrial Property of the Federal Service of Intellectual Property, Patents and Trademarks of t… [cited by applicant]
Supplementary European Search Report and the European Search Opinion Dated Aug. 4, 2021 From the European Patent Office Re. Application No. 18895004.2. (6 Pages). [cited by applicant]
Zorba et al. “Autonomic Nervous System Dysfunction in Lifelong Premature Ejaculation: Analysis of Heart Rate Variability”, Urology, 80(6):1283-1286, Dec. 2012. [cited by applicant]
International Preliminary Report on Patentability Dated Jul. 9, 2020 From the International Bureau of WIPO Re. Application No. PCT/IL2018/051402. (7 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Apr. 11, 2019 From the International Searching Authority Re. Application No. PCT/IL2018/051402. (10 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated May 18, 2017 From the International Searching Authority Re. Application No. PCT/IB182016/001731. (17 Pages). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 1). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 2). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 3). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 4). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 5). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 6). [cited by applicant]
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5™, Association Psychiatric Association, 5th Ed., III: 1-947, 2013. (Part 7). [cited by applicant]
Case-Lo et al. “Delayed Ejaculation: Symptoms, Causes, Diagnosis, Treatment, Complications, Outlook, Diet and DE”, HealthLine, 11 P., Jul. 21, 2016. [cited by applicant]
Donatucci “Etiology of Ejaculation and Pathophysiology of Premature Ejaculation”, The Journal of Sexual Medicine, 3(Suppl.4): 303-308, Sep. 2006. [cited by applicant]
Doucet et al. “Neuromuscular Electrical Stimulation for Skeletal Muscle Function”, Yale Journal of Biology and Medicine 85(2): 201-215, Jun. 2012. [cited by applicant]
Eisenberg et al. “Anogenital Distance as a Measure of Human Male Fertility”, Journal of Assisted Reproduction and Genetics 32(3):479-484, Mar. 2015. [cited by applicant]
Eisenberg et al. “The Relationship Between Anogenital Distance and Age”, Andrology, 1(1): 90-93, Jan. 2013. [cited by applicant]
Porter “Delayed Ejaculation DSM-5 302.74 (N53.11)”, Theravive, Therapedia, 3 P., 2019. [cited by applicant]